Works matching IS 09024441 AND DT 2021 AND VI 106 AND IP 5


Results: 20
    1

    Reference values for the EORTC QLQ‐C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.

    Published in:
    European Journal of Haematology, 2021, v. 106, n. 5, p. 697, doi. 10.1111/ejh.13601
    By:
    • Vachon, Hugo;
    • Mierzynska, Justyna;
    • Taye, Mekdes;
    • Pe, Madeline;
    • Coens, Corneel;
    • Martinelli, Francesca;
    • Fortpied, Catherine;
    • Flechtner, Hans‐Henning;
    • Vestmoe Maraldo, Maja;
    • Hutchings, Martin;
    • Meijnders, Paul;
    • Aleman, Berthe;
    • Lugtenburg, Pieternella;
    • Spina, Michele;
    • André, Marc;
    • Hertzberg, Mark;
    • Briones, Javier;
    • Bottomley, Andrew
    Publication type:
    Article
    2
    3

    Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.

    Published in:
    European Journal of Haematology, 2021, v. 106, n. 5, p. 724, doi. 10.1111/ejh.13604
    By:
    • Solana‐Altabella, Antonio;
    • Boluda, Blanca;
    • Rodríguez‐Veiga, Rebeca;
    • Cano, Isabel;
    • Acuña‐Cruz, Evelyn;
    • Blanco, Albert;
    • Marco‐Ayala, Javier;
    • Puerta, Rosalía;
    • Díaz‐González, Álvaro;
    • Piñana, José L.;
    • Sanz, Jaime;
    • Sempere, Amparo;
    • Cervera, José;
    • Barragán, Eva;
    • Sargas, Claudia;
    • Ballesta‐López, Octavio;
    • Megías‐Vericat, Juan Eduardo;
    • Martínez‐Cuadrón, David;
    • Sanz, Miguel Á.;
    • Montesinos, Pau
    Publication type:
    Article
    4

    Prognostic impact of early‐versus‐late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT.

    Published in:
    European Journal of Haematology, 2021, v. 106, n. 5, p. 708, doi. 10.1111/ejh.13602
    By:
    • Garderet, Laurent;
    • Sbianchi, Giulia;
    • Iacobelli, Simona;
    • Blaise, Didier;
    • Byrne, Jenny L.;
    • Remenyi, Peter;
    • Apperley, Jane F.;
    • Touzeau, Cyrille;
    • Isaksson, Cecilia;
    • Browne, Paul;
    • Mayer, Jiri;
    • Lenhoff, Stig;
    • Gonzalez Muniz, Soledad;
    • Parody Porras, Rocio;
    • Basak, Grzegorz;
    • Poire, Xavier;
    • Trneny, Marek;
    • Nagler, Arnon;
    • Michieli, Mariagrazia;
    • Tanase, Alina
    Publication type:
    Article
    5
    6

    Cover Image.

    Published in:
    European Journal of Haematology, 2021, v. 106, n. 5, p. i, doi. 10.1111/ejh.13634
    By:
    • Hansen, Sarah;
    • Alduaij, Waleed;
    • Biggs, Catherine M.;
    • Belga, Sara;
    • Luecke, Kai;
    • Merkeley, Hayley;
    • Chen, Luke Y. C.
    Publication type:
    Article
    7
    8

    The impact of lenalidomide maintenance on second‐line chemotherapy in transplant eligible patients with multiple myeloma.

    Published in:
    European Journal of Haematology, 2021, v. 106, n. 5, p. 673, doi. 10.1111/ejh.13596
    By:
    • Cherniawsky, Hannah M.;
    • Kukreti, Vishal;
    • Reece, Donna;
    • Masih‐Khan, Esther;
    • McCurdy, Arleigh;
    • Jimenez‐Zepeda, Victor H.;
    • Sebag, Michael;
    • Song, Kevin;
    • White, Darrell;
    • Stakiw, Julie;
    • LeBlanc, Richard;
    • Reiman, Anthony;
    • Louzada, Martha;
    • Aslam, Muhammad;
    • Kotb, Rami;
    • Gul, Engin;
    • Atenafu, Eshetu;
    • Venner, Christopher P.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Issue Information.

    Published in:
    European Journal of Haematology, 2021, v. 106, n. 5, p. 595, doi. 10.1111/ejh.13445
    Publication type:
    Article
    20